moxifloxacin has been researched along with Neutropenia in 23 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 11 (47.83) | 29.6817 |
2010's | 12 (52.17) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aytekin, A; Bedir, O; Ispir, E; Kula Atik, T; Tas, D; Turhan, U; Yeniiz, E | 1 |
Przybylski, DJ; Reeves, DJ | 1 |
Knoebel, RW; Lee, P; Pettit, NN; Pisano, J | 1 |
Dixit, A; Jones, S; Karandikar, MV; Nakamura, MM | 1 |
Dugar, M; Rankin, WA; Rowe, E; Smith, MD | 1 |
Benjamin, RS; Frisbee-Hume, SE; Manzullo, EF; Patel, S; Rolston, KV | 1 |
Barker, EN; Chalker, VJ; Hamon, M; Jensen, J; Mitchell, J; Steer, JA; Stocki, T; Tasker, S | 1 |
Arenz, D; Böll, B; Bredenfeld, H; Chemnitz, J; Cornely, OA; Cremer, B; Hallek, M; Kaul, I; Klein, F; Mahne, M; Moritz, G; Scheid, C; Vehreschild, JJ; Vehreschild, MJ; Wassmer, G | 1 |
Hangaishi, A; Kurokawa, M; Masamoto, Y; Nannya, Y; Shinohara, A; Yoshiki, Y | 1 |
Haeusler, GM; Slavin, MA | 1 |
Berk, E; Berk, V; Bozkurt, O; Demiraslan, H; Inanc, M; Karaca, H; Ozkan, M | 1 |
Slavin, MA; Thursky, KA | 1 |
Akan, H; Akova, M; Aoun, M; Calandra, T; de Bock, R; Drgona, L; Kern, WV; Marchetti, O; Paesmans, M; Viscoli, C | 1 |
Alteraz, H; Blau, H; Fabian, I; Horev-Azaria, L; Kariv, N; Kletter, Y; Shalit, I; Shechtman, I | 1 |
Buchheidt, D; Hofheinz, R; Hummel, M | 1 |
Elliott, MA; Patel, R; Prabhu, RM | 1 |
Dmitrieva, NV; Minenko, SV; Ptushkin, VV; Sokolova, EN; Zhukov, NV | 1 |
Georgopoulos, A; Graninger, W; Grisold, AJ; Hirschl, AM; Presterl, E; Reichmann, S | 1 |
Bamias, A; Chamilos, G; Dimopoulos, MA; Efstathiou, E; Kastritis, E; Kostis, E; Papadimitriou, C; Zorzou, PM | 1 |
Bommer, M; Döhner, H; Kern, P; Kern, WV; Marre, R; Reuter, S; Sigge, A; von Baum, H | 1 |
Bille, J; Calandra, T; Cometta, A; Kern, WV; Marchetti, O; Zinner, S | 1 |
Bachelot, T; Biron, P; Chelghoum, M; Chvetzoff, G; Devaux, Y; Dussart, S; Fuhrmann, C; Geoffrois, L; Ghesquieres, H; Lancry, L; Rodrigues, I; Sebban, C | 1 |
Chang, CM; Ko, WC; Lee, HC; Lee, IW; Lee, NY; Lin, YS; Wu, CJ | 1 |
4 trial(s) available for moxifloxacin and Neutropenia
Article | Year |
---|---|
Efficacy and safety of moxifloxacin as antibacterial prophylaxis for patients receiving autologous haematopoietic stem cell transplantation: a randomised trial.
Topics: Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Agents; Aza Compounds; Bacteremia; Bacterial Infections; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Neutropenia; Pilot Projects; Placebos; Prospective Studies; Quinolines; Stem Cell Transplantation; Treatment Outcome | 2012 |
Oral antibiotics for fever in low-risk neutropenic patients with cancer: a double-blind, randomized, multicenter trial comparing single daily moxifloxacin with twice daily ciprofloxacin plus amoxicillin/clavulanic acid combination therapy--EORTC infectiou
Topics: Administration, Oral; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Clavulanic Acid; Double-Blind Method; Drug Combinations; Female; Fever; Fluoroquinolones; Humans; Injections, Intravenous; Male; Middle Aged; Moxifloxacin; Neoplasms; Neutropenia; Quinolines; Risk Factors; Treatment Outcome | 2013 |
[Efficacy of moxifloxacin (Avelox) in prophylaxis of infection in patients with profound neutropenia].
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Antineoplastic Agents; Aza Compounds; Bacterial Infections; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Neutropenia; Quinolines | 2004 |
Oral moxifloxacin or intravenous ceftriaxone for the treatment of low-risk neutropenic fever in cancer patients suitable for early hospital discharge.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Antineoplastic Agents; Aza Compounds; Ceftriaxone; Female; Fever; Fluoroquinolones; Humans; Infusions, Intravenous; Male; Middle Aged; Moxifloxacin; Neoplasms; Neutropenia; Patient Discharge; Quinolines; Risk Factors; Time Factors | 2008 |
19 other study(ies) available for moxifloxacin and Neutropenia
Article | Year |
---|---|
Moxifloxacin-induced neutropenia in 26-year-old man.
Topics: Adult; Anti-Bacterial Agents; Humans; Male; Moxifloxacin; Neutropenia | 2018 |
Moxifloxacin versus levofloxacin or ciprofloxacin prophylaxis in acute myeloid leukemia patients receiving chemotherapy.
Topics: Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Ciprofloxacin; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Fluoroquinolones; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Levofloxacin; Male; Middle Aged; Moxifloxacin; Neutropenia; Randomized Controlled Trials as Topic; Retrospective Studies | 2017 |
Moxifloxacin versus levofloxacin for antibacterial prophylaxis in acute leukemia patients.
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Female; Humans; Leukemia, Myeloid, Acute; Levofloxacin; Male; Middle Aged; Moxifloxacin; Neutropenia; Retrospective Studies | 2019 |
Safety and Tolerability of Moxifloxacin in Children.
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Alanine Transaminase; Anti-Bacterial Agents; Aspartate Aminotransferases; Bacterial Infections; Bilirubin; Blood Cell Count; Child; Child, Preschool; Drug Administration Schedule; Female; Fluoroquinolones; Humans; Infant; Long QT Syndrome; Male; Moxifloxacin; Neutropenia; Retrospective Studies; Seizures | 2018 |
"My foot hurts": a flare of rheumatoid arthritis?
Topics: Arthritis, Rheumatoid; Aza Compounds; Azithromycin; Drug Therapy, Combination; Fluoroquinolones; Humans; Legionella longbeachae; Legionellosis; Male; Middle Aged; Moxifloxacin; Neutropenia; Osteomyelitis; Quinolines; Steroids | 2009 |
Oral moxifloxacin for outpatient treatment of low-risk, febrile neutropenic patients.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Ambulatory Care; Anti-Infective Agents; Aza Compounds; Feasibility Studies; Female; Fever; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Neutropenia; Pilot Projects; Quinolines | 2010 |
A novel hemotropic Mycoplasma (hemoplasma) in a patient with hemolytic anemia and pyrexia.
Topics: Anemia, Hemolytic; Anti-Bacterial Agents; Aza Compounds; Chronic Disease; Cluster Analysis; DNA, Bacterial; DNA, Ribosomal; Doxycycline; Female; Fever; Fluoroquinolones; Humans; Middle Aged; Molecular Sequence Data; Moxifloxacin; Mycoplasma; Mycoplasma Infections; Neutropenia; Phylogeny; Quinolines; RNA, Ribosomal, 16S; Sequence Analysis, DNA | 2011 |
Moxifloxacin is more effective than tosufloxacin in reducing chemotherapy-induced febrile neutropenia in patients with hematological malignancies.
Topics: Adult; Aged; Antibiotic Prophylaxis; Antineoplastic Agents; Aza Compounds; Female; Fever; Fluoroquinolones; Hematologic Neoplasms; Humans; Male; Middle Aged; Moxifloxacin; Naphthyridines; Neutropenia; Quinolines; Retrospective Studies; Risk Factors; Treatment Outcome | 2013 |
Fluoroquinolone prophylaxis: worth the cost?
Topics: Antineoplastic Agents; Aza Compounds; Female; Fever; Fluoroquinolones; Hematologic Neoplasms; Humans; Male; Moxifloxacin; Naphthyridines; Neutropenia; Quinolines | 2013 |
Moxifloxacin-associated neutropenia.
Topics: Adult; Anti-Bacterial Agents; Aza Compounds; Female; Fluoroquinolones; Humans; Leukocyte Count; Moxifloxacin; Neutropenia; Pneumonia; Quinolines | 2013 |
Outpatient therapy for fever and neutropenia is safe but implementation is the key.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Female; Fever; Fluoroquinolones; Humans; Male; Moxifloxacin; Neoplasms; Neutropenia; Quinolines | 2013 |
Immunomodulatory and protective effects of moxifloxacin against Candida albicans-induced bronchopneumonia in mice injected with cyclophosphamide.
Topics: Animals; Anti-Infective Agents; Aza Compounds; Body Weight; Bronchopneumonia; Candidiasis; Ceftazidime; Cephalosporins; Cyclophosphamide; Cytokines; Fluoroquinolones; Lung; Male; Mice; Mice, Inbred BALB C; Moxifloxacin; Neutropenia; Protein Synthesis Inhibitors; Quinolines; Survival | 2002 |
Severe Chlamydia pneumoniae infection in a patient with mild neutropenia during treatment of Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Aza Compounds; Bleomycin; Chlamydophila Infections; Chlamydophila pneumoniae; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Fluoroquinolones; Hodgkin Disease; Humans; Imipenem; Immunocompromised Host; Moxifloxacin; Neutropenia; Pneumonia, Bacterial; Quinolines; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; Vincristine | 2004 |
Apparent failure of moxifloxacin to prevent ciprofloxacin- and levofloxacin-susceptible Pseudomonas aeruginosa bacteremia in neutropenic patients undergoing peripheral blood stem cell transplantation.
Topics: Anti-Infective Agents; Aza Compounds; Bacteremia; Ciprofloxacin; Female; Fluoroquinolones; Hematopoietic Stem Cell Transplantation; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Neutropenia; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines; Treatment Failure | 2004 |
Viridans streptococci in endocarditis and neutropenic sepsis: biofilm formation and effects of antibiotics.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; Bacteremia; Biofilms; Blood; Culture Media; Endocarditis, Bacterial; Female; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Neutropenia; Penicillins; Quinolines; Streptococcal Infections; Teicoplanin; Viridans Streptococci | 2005 |
Outpatient treatment of low-risk neutropenic fever in cancer patients using oral moxifloxacin.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Ambulatory Care; Antineoplastic Agents; Aza Compounds; Female; Fever; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Neoplasms; Neutropenia; Quinolines; Risk Assessment; Safety; Treatment Outcome | 2005 |
Moxifloxacin prophylaxis in neutropenic patients.
Topics: Anti-Infective Agents; Antibiotic Prophylaxis; Aza Compounds; Bacteremia; Clostridioides difficile; Enterocolitis, Pseudomembranous; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Moxifloxacin; Neutropenia; Ofloxacin; Quinolines | 2006 |
In vitro antimicrobial activity of moxifloxacin against bacterial strains isolated from blood of neutropenic cancer patients.
Topics: Anti-Bacterial Agents; Aza Compounds; Bacteria; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Moxifloxacin; Neoplasms; Neutropenia; Quinolines | 2006 |
Moxifloxacin-associated neutropenia in a cirrhotic elderly woman with lower extremity cellulitis.
Topics: Aged; Ankle; Anti-Infective Agents; Aza Compounds; Blood Cell Count; Cellulitis; Female; Fluoroquinolones; Humans; Liver Cirrhosis; Moxifloxacin; Neutropenia; Quinolines | 2008 |